5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.32▼ | 1.36▼ | 1.36▼ | 1.51▼ | N/A |
MA10 | 1.36▼ | 1.44▼ | 1.47▼ | 1.74▼ | N/A |
MA20 | 1.44▼ | 1.55▼ | 1.59▼ | N/A | N/A |
MA50 | 1.62▼ | 1.78▼ | N/A | N/A | N/A |
MA100 | 1.76▼ | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.005▼ | -0.017▼ | -0.013▼ | N/A | N/A |
RSI | 30.929▼ | 30.174▼ | 30.909▼ | N/A | N/A |
STOCH | 12.151▼ | 10.952▼ | 10.952▼ | N/A | N/A |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | N/A | N/A |
CCI | -96.643 | -103.123▼ | -123.689▼ | N/A | N/A |
Friday, August 01, 2025 11:26 AM
We recently published 13 Stocks That Jim Cramer Recently Talked About. Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently discussed. Merck & Co., Inc. (NYSE:MRK)’s shares have lost ...
|
Thursday, July 31, 2025 11:14 AM
President Donald Trump sent letters to 17 leading pharmaceutical manufacturers, including Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE), and Merck (NYSE:MRK), on Thursday, demanding that they take steps to ...
|
Wednesday, July 30, 2025 08:59 PM
Merck & Co., Inc. (NYSE:MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, Oppenheimer analyst Ken Wong noted that Outperform-rated Veeva announced that ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/08/25 | 1.348 | 1.36 | 1.19 | 1.21 | 172,800 |
31/07/25 | 1.56 | 1.58 | 1.31 | 1.40 | 274,900 |
30/07/25 | 1.58 | 1.66 | 1.52 | 1.56 | 174,400 |
29/07/25 | 1.74 | 1.74 | 1.52 | 1.64 | 277,000 |
28/07/25 | 1.80 | 1.93 | 1.66 | 1.75 | 326,100 |
25/07/25 | 1.90 | 1.90 | 1.685 | 1.73 | 284,382 |
24/07/25 | 2.08 | 2.36 | 1.86 | 1.91 | 1,217,500 |
23/07/25 | 1.96 | 2.07 | 1.96 | 2.02 | 290,352 |
22/07/25 | 2.01 | 2.0742 | 1.91 | 2.01 | 252,086 |
21/07/25 | 2.20 | 2.20 | 1.90 | 2.15 | 794,541 |
|
|
||||
|
|
||||
|
|